Resmed Inc
NYSE:RMD
Resmed Inc
Operating Income
Resmed Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Resmed Inc
NYSE:RMD
|
Operating Income
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Resmed Inc's Operating Income?
Operating Income
1.3B
USD
Based on the financial report for Mar 31, 2024, Resmed Inc's Operating Income amounts to 1.3B USD.
What is Resmed Inc's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was 15%. The average annual Operating Income growth rates for Resmed Inc have been 13% over the past three years , 16% over the past five years , and 13% over the past ten years .